
Profitability, historical returns, and peer comparisons.
According to Entia Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is 106.80%. This represents a change of 328.06% compared to the average of 24.95% of the last 4 quarters.
The mean historical ROE of Entia Biosciences, Inc. over the last ten years is 408.23%. The current 106.80% ROE has changed -73.84% with respect to the historical average. Over the past ten years (40 quarters), ERGO's ROE was at its highest in in the June 2015 quarter at 1.30%. The ROE was at its lowest in in the September 2010 quarter at -572.94%.
Average
408.23%
Median
270.04%
Minimum
-190.21%
Maximum
2.26%
Discovering the peaks and valleys of Entia Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 591.35%
Maximum Annual ROE = 2.26%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -190.21%
| Year | ROE | Change |
|---|---|---|
| 2016 | 74.89% | -75.41% |
| 2015 | 304.52% | -86.54% |
| 2014 | 2.26% | 561.08% |
| 2013 | 342.20% | 45.28% |
| 2012 | 235.55% | -64.61% |
| 2011 | 665.67% | 60.41% |
| 2010 | 414.98% | -318.17% |
| 2009 | -190.21% | 591.35% |
| 2008 | -27.51% | -Infinity% |
The current ROE of Entia Biosciences, Inc. (ERGO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
880.54%
5-year avg
643.88%
10-year avg
408.23%
Entia Biosciences, Inc.’s ROE is greater than AVAX Technologies, Inc. (-344.15%), less than DNAPrint Genomics, Inc. (316.59%), less than Statera Biopharma, Inc. (6.68%), less than RepliCel Life Sciences Inc. (1.86%), less than Biostax Corp. (67.11%), greater than Better Therapeutics, Inc. (-221.99%), greater than Panacos Pharmaceuticals, Inc. (-85.57%), less than South American Gold Corp. (8.15%), less than WOWI, Inc. (157.95%), greater than Bangi Inc. (-309.98%),
| Company | ROE | Market cap |
|---|---|---|
| -344.15% | $6.89K | |
| 316.59% | $12.89K | |
| 6.68% | $14.28K | |
| 1.86% | $7.36K | |
| 67.11% | $15.74K | |
| -221.99% | $5.45K | |
| -85.57% | $5.36K | |
| 8.15% | $67.73K | |
| 157.95% | $3.38K | |
| -309.98% | $5.25K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entia Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Entia Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Entia Biosciences, Inc.'s ROE?
How is the ROE calculated for Entia Biosciences, Inc. (ERGO)?
What is the highest ROE for Entia Biosciences, Inc. (ERGO)?
What is the 3-year average ROE for Entia Biosciences, Inc. (ERGO)?
What is the 5-year average ROE for Entia Biosciences, Inc. (ERGO)?
How does the current ROE for Entia Biosciences, Inc. (ERGO) compare to its historical average?